Youtor
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=-6fbb3C9jxA
Ms. Emilia Balboa Beltran, a PhD student at the Universidad de Santiago de Compostela, in Spain, discusses a case reported in the September 2015 issue of Mayo Clinic Proceedings, which notes the first clinical description of a cancer patient with a heterozygous germline codon-stop mutation in the TYMS gene and hypothesizes this mutation may contribute to the drug response and toxicities suffered by the patient. • Available at: http://tinyurl.com/p7b457m
#############################
